Multicentre Italian Trials in Ovarian cancer (MITO) translational group. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study

Bagnoli, M; Canevari, S; Califano, D; Losito, S; Maio, Md; Raspagliesi, F; Carcangiu ML, ; Toffoli, G; Cecchin, E; Sorio, R; Canzonieri, V; Russo, D; Scognamiglio, G; Chiappetta, G; Baldassarre, G; Lorusso, D; Scambia, G; Zannoni, Gf; Savarese, A; Carosi M, ; Scollo, P; Breda, E; Murgia, V; Perrone, F; Pignata, S; De Cecco, L; Mezzanzanica, D